Newswise — In a recently published study, Vera Bittner, M.D., professor in the University of Alabama at Birmingham Division of Cardiovascular Disease, and colleagues have demonstrated that weight cycling is associated with a lower rate of adverse cardiovascular outcomes in women with suspected ischemia, such as stroke, heart attack and heart failure.
Using data from the NIH-funded Women’s Ischemia Syndrome Evaluation study, Bittner and colleagues set out to determine in the WISE population whether weight cycling —defined as an intentional loss of at least 10 pounds at least three times — during a woman’s lifetime was related to the composite outcome of all cause death, cardiovascular death, nonfatal heart attack, non-fatal stroke and hospitalization for heart failure or the components of this composite outcome.
“Given prior studies that enrolled predominantly men, we thought we would find an adverse relationship; but we found the opposite,” Bittner said.
Women who reported weight cycling compared to those who did not had different baseline characteristics. Still, even after adjusting for these differences in baseline characteristics and other variables known to be prognostic in the WISE cohort in a logistic regression model, researchers found weight cycling was associated with a lower risk of the combined outcome and a lower risk of cardiovascular death.
“It is important to remember, however, that the amount of weight lost and gained during weight cycling was not very large, and we do not know whether weight cycling with much larger shifts in weight would be free of harm,” Bittner said.
She added that the data suggest there may be a sex difference in the impact of weight cycling, and that this should be explored in larger datasets and among less selected populations of women and men.
“It is important to remember that maintenance of normal weight throughout one’s lifetime is the best option,” she said. “However, once individuals gain weight, efforts at improving weight are important, and individuals should not be discouraged from trying again if they regain the weight.”
UAB was a participating site in the NIH-funded WISE study with UAB Professor William Rogers, M.D., as PI and Bittner serving as a co-investigator. The study enrolled female participants with suspected myocardial ischemia from 1996-2001 and followed them for several years after that.
C. Noel Bairey Merz, M.D., from the Barbra Streisand Women’s Heart Center at Cedars-Sinai Medical Center in Los Angeles, served as primary investigator for this study.
This work was supported by contracts from the National Heart, Lung and Blood Institute.